Medical Marijuana, Inc. Strengthens Europe Leadership Team With Appointment of Alex Grapov As International Vice President


SAN DIEGO, May 22, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that it has appointed Alex Grapov as its International Vice President. Grapov’s first priority will be to open Medical Marijuana Inc. subsidiary  Kannaway LLC‘s Kannaway® Europe operation. Kannaway®, the first hemp lifestyle network to offer phyto-cannabinoid botanical products, recently announced its expansion into Europe with the establishment of Kannaway® Europe, which is expected to be fully operational by Q4 2017.

Grapov has over 10 years’ experience in international business development and expansion. Prior to his new role, Russian-native Grapov served as Managing Director for European Operations and Senior Director of European Sales at two U.S. billion dollar companies, driving annual sales exceeding $100 million.

“We are pleased that Alex will be joining our team as we embark on sharing our products, culture and mission with the people of Europe and all over the world,” said Kannaway® CEO Blake Schroeder. “Alex has worked intimately within the European market space and we believe his background and strengths in sales strategy, product introductions, market expansion, leadership and field development will help ensure Kannaway’s® growth in Europe, the second fastest growth region in the world of direct sales.”

“It’s a privilege to join a company like Kannaway® and I am excited to work with such a high caliber of professionals to help drive Kannaway’s® unparalleled vision and exceptional product line throughout Europe,” said Grapov. “I am committed to creating a seamless opportunity for all the Kannaway® brand ambassadors to expand their business around the globe and create a true movement to enhance lives around the world. I couldn’t be more excited for the future and believe as a Company built on ethics and integrity, Kannaway® is perfectly positioned to be a success in Europe and bring value to European communities.”

Grapov received his B.S. in Biology and Chemistry from the University of Utah.

Information on how to become a European Kannaway® Brand Ambassador will be made available prior to the Company’s official European launch later this year.

About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

Public Relations Contact:
Andrew Hard
Chief Executive Officer CMW Media
P. 888-829- 0070
[email protected]